Albumin Market Size, Growth Rate and Regional Share (2025–2031)

The albumin market size is projected to reach US$ 9.22 billion by 2031 from US$ 6.06 billion in 2024. The market is expected to register a CAGR of 6.3% during 2025–2031.  

Albumin Market Analysis

Human albumin is popularly applied in treating trauma, burns, and hypoalbuminemia, whereas recombinant and bovine sources are increasingly adopted in biopharmaceutical production and cell culture. Rising incidences of liver and kidney diseases favor market growth. Advances in purification technology and recombinant production techniques improve product safety and efficacy. Nevertheless, dependency on plasma donations and regulatory issues act as restraints. R&D investments and strategic partnerships influence market dynamics.

Albumin Market Overview

Albumin is a water-soluble protein obtained from human serum or made recombinantly. It is used extensively in the formulation of drugs, the manufacturing of vaccines, and as a stabilizer in medicines. Its ability to bind strongly renders it useful in burn, trauma, and hypoalbuminemia therapies. The protein is increasingly used in cell culture media and as an excipient in biopharmaceutical products. An increase in demand for plasma-derived therapies, improvements in recombinant technologies, and a rising number of surgical interventions drive market growth. Increasing regulatory support and developing healthcare infrastructure in emerging markets also propels market growth. However, supply chain issues, plasma sourcing ethics concerns, and strict regulations could act as challenges. Advances in recombinant albumin and increasing research activities define the changing landscape of this market.  

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Albumin Market: Strategic Insights

Albumin Market Drivers and Opportunities

Market Drivers:

• Rising Demand for Plasma-Derived Therapies: The increasing prevalence of chronic conditions such as liver disease, burns, and shock fuels demand for albumin-based treatments in therapeutic and supportive care applications.
• Expansion of Biopharmaceutical Applications: Albumin is widely used as a stabilizing agent in biologics, vaccines, and drug delivery systems, leading to greater adoption in the biopharmaceutical industry.

Market Opportunities:

• Advancements in Recombinant Albumin Technology: Innovations in recombinant albumin production offer a sustainable, non-human-derived alternative, reducing dependency on blood donations and meeting global demand with improved safety profiles.
• Emerging Markets Expansion: Developing countries invest heavily in healthcare infrastructure, creating demand for albumin-based products in diagnostics, critical care, and therapeutic treatments.

Albumin Market Report Segmentation Analysis

The albumin market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:

By Source:

• Natural Albumin: It is known for its proven safety, effectiveness in treating critical conditions, and widespread clinical acceptance. Its biocompatibility and therapeutic benefits make it a preferred choice for fluid replacement and plasma volume expansion. Natural albumin is sub-segmented as human serum albumin, bovine serum albumin, and plant serum albumin.

• Recombinant Albumin: Recombinant albumin offers a safer, ethical alternative to plasma-derived albumin. The consistent quality, reduced risk of infections, and scalability in biopharmaceuticals drive its adoption in advanced drug delivery and therapeutic applications.  

By Application:

• Therapeutic Applications: Therapeutic applications address critical medical needs such as shock, burns, and hypoalbuminemia. Their effectiveness in fluid replacement and blood volume maintenance in emergency and surgical care fuels widespread clinical use. Therapeutic applications include liver and kidney diseases, surgery, hypovolemia, hypoalbuminemia, and others.
• Drug Delivery: Albumin’s natural ability to bind drugs increases efficacy, reduces side effects, and enables controlled release, making it a vital component in innovative biopharmaceutical formulations and treatments.
• Disease Diagnostics: Albumin is a key biomarker for liver, kidney, and nutritional disorders. Accurate albumin measurement supports early diagnosis, disease monitoring, and personalized treatment, increasing global demand for albumin-based diagnostic kits and tests.
• Research: Ongoing research into recombinant albumin for drug delivery and regenerative medicine is expanding its potential applications, driving innovation and attracting global investment in product development.
• Others: Albumin’s moisturizing and skin-repair properties are useful in anti-aging and beauty products. Its natural protein benefits promote skin health, increasing demand for albumin-based formulations in skincare and personal care sectors.

By End User:

• Hospitals and Clinics
• Pharmaceutical and Biotechnological Companies
• Research Institutes
• Diagnostic Laboratories
• Homecare Settings
• Others

By Geography:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
  

The regional trends and factors influencing the Albumin Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Albumin Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Albumin Market Report Scope

Albumin Market Players Density: Understanding Its Impact on Business Dynamics

The Albumin Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Albumin Market Share Analysis by Geography

North America dominates the albumin market due to its advanced healthcare infrastructure, high prevalence of chronic diseases requiring albumin therapies, and strong presence of key pharmaceutical companies. The region benefits from investments in research and development, enabling innovations such as recombinant albumin. Additionally, well-established blood plasma collection systems and favorable regulatory frameworks support a steady supply and adoption of albumin-based products, driving adoption in therapeutic and biopharmaceutical sectors.

Asia Pacific is growing at the fastest rate due to improving healthcare infrastructure and developing pharmaceutical sectors. Emerging markets in Latin America, the Middle East, and Africa have untapped opportunities for albumin providers to expand.

The growth of the albumin market varies across regions due to factors such as an aging population and the increasing prevalence of mobility-related disorders, which drive demand for albumin-based therapies. Below is a summary of market share and trends by region:

1. North America

• Market Share: Holds a significant portion of the global market
• Key Drivers:
  • Advanced Healthcare Infrastructure
  • High Prevalence of Chronic Diseases
• Trends: Greater Adoption of Recombinant Albumin

2. Europe

• Market Share: Substantial market share
• Key Drivers:
  • Rising Demand for Plasma-Derived Therapies
  • Strong Healthcare Infrastructure and Public Funding
• Trends: Shift Toward Recombinant & Animal-Free Albumin.

3. Asia Pacific

• Market Share: Fastest-growing region with a rising market share every year
• Key Drivers:
  • Growing Prevalence of Chronic Diseases
  • Expanding Healthcare Infrastructure
• Trends: Expansion of Recombinant & Synthetic Albumin Production.

4. South and Central America

• Market Share: Growing market with steady progress
• Key Drivers:
  • Growing Awareness and Adoption of Advanced Therapies
  • Expansion of Local Biopharmaceutical Industry
• Trends: Improvement of Local Production & Plasma Fractionation.

5. Middle East and Africa

• Market Share: Although small, but growing quickly
• Key Drivers:
  • Rising Demand for Plasma-Derived Products
  • Expansion of Diagnostic and Research Capabilities
• Trends: Rapid Growth of Recombinant Albumin / Cell Culture Supplements.

Albumin Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as CSL Ltd and Grifols SA. Niche providers also contribute to the competitive landscape across regions.

This high level of competition urges companies to stand out by offering:

• Advanced Products
• Value-added services like customization and sustainable solutions
• Competitive pricing models
• Compliance with regulatory guidelines

Opportunities and Strategic Moves

• Advancements in recombinant albumin production offer scalable, virus-free alternatives to plasma-derived sources. Healthgen Biotechnology's rice-derived recombinant human albumin injection, approved by China's NMPA, exemplifies the potential of plant-based platforms in large-scale production.
• Albumin's role as a stabilizer and carrier in drug formulations, particularly in nanoparticle-based systems for cancer therapies, is expanding.
• The shift toward personalized medicine is increasing the demand for customized drug formulations using blood albumin, especially in oncology.

Major Companies operating in the Albumin Market are:

1. CSL Ltd
2. Grifols SA
3. Taibang Bio Group Co. Ltd.
4. Merck KGaA
5. Octapharma AG
6. HiMedia Laboratories Pvt Ltd
7. Takeda Pharmaceutical Co Ltd
8. Thermo Fisher Scientific Inc
9. InVitria
10. Biotest AG.
11. Medxbio Pte Ltd
12. Lazuline Biotech Private Limited
13. Cyagen Biosciences
14. Sartorius AG
15. Aspira Chemical
16. Lee BioSolutions
17. Reliance Life Sciences Private Limited
18. Kedrion SpA
19. Biorbyt Ltd.
20. Akron Biotech

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analyzed during the course of research:

1. Albumedix Ltd. (Sartorius AG)
2. Ventria Bioscience (InVitria)
3. Biorbyt Ltd. (UK)
4. Medxbio Pte Ltd. (Singapore)
5. Akron Biotech (US)
6. RayBiotech Inc. (US)
7. Seracare Life Sciences Inc. (US)
8. Bristol-Myers Squibb Company (US)
9. Recombinant Technologies Inc. (US)
10. Mitsubishi Tanabe Pharma Corporation (Japan)
11. Baxter International Inc. (US)
12. Hualan Bio (China)
13. China Biologic Products Holdings, Inc. (China)
14. Shanghai RAAS Blood Products Co., Ltd. (China)
15. LFB Group (France)
16. Ventria Bioscience Inc. (US)
17. HiMedia Laboratories Pvt. Ltd. (India)
18. Medxbio Pte. Ltd. (Singapore)
19. MilliporeSigma (US)
20. RayBiotech Inc. (US)
21. Seracare Life Sciences Inc. (US)
22. Akron Biotech (US)
23. Bristol-Myers Squibb Company (US)
24. Dyadic International, Inc. (US)
25. Proliant Health and Biologicals (US)
26. Bio Products Laboratory Ltd. (UK)
27. Albumin Bioscience (US)
28. Lazuline Bio (India)

Albumin Market News and Recent Developments

• Healthgen Biotechnology received regulatory approval in April 2025 from China's National Medical Products Administration for its rice-derived recombinant human albumin injection This plant-based platform enables large-scale production, addressing hypoalbuminemia with a sustainable and animal-free approach.
• Ventria Bioscience introduced a plant-based recombinant albumin in June 2024 The new plant-based recombinant albumin offers a sustainable and animal-free alternative for cell culture media, regenerative medicine, and vaccine stabilization.  

Albumin Market Report Coverage and Deliverables

The "Albumin Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Albumin Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Albumin Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Albumin Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the albumin Market
• Detailed company profiles